Literature DB >> 2584637

Blindness influences the growth of institutionalized prepubertal subjects.

A Bellastella1, A A Sinisi, C Raiola, L Perrone, S Iorio, F Parlato, A Mazzuca, M Faggiano.   

Abstract

To investigate if blindness influences the growth rate of young subjects we measured height and weight of 71 prepubertal blind subjects (33 females and 38 males) aged 7-10 yr, in Tanner stage one puberty, living at the Institute "Martuscelli" for young blind individuals in Naples, Italy. They were divided into two groups: group 1 consisting of 27 subjects (14 females and 13 males) with total blindness; group 2 consisting of 44 subjects (20 females and 24 males) having only a light perception. The distribution in quintiles of their height and weight was compared by X2 test for trend to that of an age-matched large population (7902 subjects: 3808 females and 4094 males) of primary school from the same district. A stature significantly lower than controls was evidenced in both group 1 (p = 0.0006) and in group 2 (p = 0.008). When the comparison is performed taking into account the sex of subjects, the girls of both group 1 (p = 0.0014) and group 2 (p = 0.0004) show a stature significantly lower than female controls, whereas the stature of boys of both groups did not differ from that of male controls. No statistically significant differences in weight distribution were found between controls and either group 1 and group 2. Our results suggest that total or partial blindness could influence negatively the growth of prepubertal subjects; in particular it can cause short stature or growth delay especially in female sex.

Entities:  

Mesh:

Year:  1989        PMID: 2584637     DOI: 10.1007/bf03350015

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  9 in total

1.  Blindness, biologic rhythms, and menarche.

Authors:  J B Thomas; D J Pizzarello
Journal:  Obstet Gynecol       Date:  1967-10       Impact factor: 7.661

2.  Absent sleep peak of growth hormone release in blind subjects: ccorrelation with sleep EEG stages.

Authors:  D T Krieger; S Glick
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

3.  Blindness and menarche.

Authors:  K Magee; J Basinska; B Quarrington; H C Stancer
Journal:  Life Sci       Date:  1970-01-01       Impact factor: 5.037

Review 4.  Growth hormone neuroregulation and its alterations in disease states.

Authors:  C Dieguez; M D Page; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1988-01       Impact factor: 3.478

Review 5.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

6.  Influence of blindness on plasma luteinizing hormone, follicle-stimulating hormone, prolactin, and testosterone levels in prepubertal boys.

Authors:  A Bellastella; T Criscuolo; A A Sinisi; S Iorio; A Mazzuca; F Parlato; L Perrone; M Faggiano
Journal:  J Clin Endocrinol Metab       Date:  1987-04       Impact factor: 5.958

7.  Plasma thyrotropin, thyroxine, triiodothyronine, free thyroxine, free triiodothyronine, and cortisol levels in blind prepubertal boys.

Authors:  A Bellastella; T Criscuolo; A A Sinisi; S Iorio; A Mazzuca; F Parlato; L Perrone; M Faggiano
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

8.  L-Dopa stimulated growth hormone release in the blind.

Authors:  A Bellastella; C F Colucci; B D'Alessandro; M Lo Cicero
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

9.  Different types of melatonin circadian secretory rhythms in some blind subjects.

Authors:  A J Lewy; D A Newsome
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

  9 in total
  3 in total

Review 1.  Light, blindness and endocrine secretions.

Authors:  A Bellastella; G Amato; A Bizzaro; C Carella; T Criscuolo; S Iorio; V I Muccitelli; G Pisano; A A Sinisi; A De Bellis
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

2.  Twenty-four hour melatonin pattern in acromegaly: effect of acute octreotide administration.

Authors:  A A Sinisi; D Pasquali; A D'Apuzzo; D Esposito; T Venditto; T Criscuolo; A De Bellis; A Bellastella
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

3.  Normal plasma insulin-like growth factor I levels and impaired final stature in adult blind subjects.

Authors:  A Bellastella; T Criscuolo; S Iorio; F Parlato; A A Sinisi; A M Sinisi; D Pasquali; G Pisano
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.